News

Recent Posts

• Trial of BAT8006 for form of ovarian cancer doses 1st patient
• EU panel backs 1st-line Sarclisa for transplant-eligible myeloma
• Revuforj gets FDA priority review for AML with NPM1 mutations
• Medicovestor’s pancreatic cancer therapy named FDA orphan drug
• Reyobiq trial for high-grade pediatric glioma approved by FDA